Kraj: Australia
Język: angielski
Źródło: Department of Health (Therapeutic Goods Administration)
salbutamol sulfate, Quantity: 264 microgram
GlaxoSmithKline Australia Pty Ltd
Insufflation
Excipient Ingredients: lactose monohydrate
Inhalation
128's rotacaps (8 x 16 blister strips)
(S1) This Schedule is intentionally blank
For the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm. Ventolin Rotacaps are indicated for the above conditions in those patients unable to use a pressurised aerosol bronchodilator satisfactorily. Patients most likely to benefit from the use of Rotacaps are: 1) Children from 3 to 6 years of age who are too young to operate a metered aerosol. 2) Patients who have difficulty synchronising deep inhalation with actuation of a metered aerosol. 3) Patients who are sensitive to freon propellants.
Visual Identification: Capsule with a pale blue opaque cap and clear body containing a small quantity of white powder. Each capsule is printed with ?Salbutamol 200? in light red once on the cap and an arrow on the body.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Listed (Export Only)
2021-07-23